000			02249nam a2200457 i 4500
999			_c279693 _d279693
001			on1084975619
003			OCoLC
005			20190314115134.0
006			m o d f
007			cr bn||||a||||
008			190208s2019 dcu ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a1019-C-01 (online)
086	0		_aY 4.C 73/8:115-110
088			_aSerial no. 115-110 (United States. Congress. House. Committee on Energy and Commerce)
099			_aY 4.C 73/8:115-110
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Oversight and Investigations,
245	1	4	_aThe Drug Enforcement Administration's role in combating the opioid epidemic : _bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 20, 2018.
246	3		_aDEA's role in combating the opioid epidemic
264		1	_aWashington : _bU.S. Government Publishing Office, _c2019.
300			_a1 online resource (iii, 101 pages)
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_a"Serial No. 115-110."
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588			_aDescription based on online resource, PDF version; title from title page (govinfo, viewed Feb. 8, 2019).
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. _tDrug Enforcement Administration's role in combating the opioid epidemic _w(OCoLC)1084489106
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo115903
050		4	_aKF27 _b.E5546 2018a
610	1	0	_aUnited States. _bDrug Enforcement Administration _xCustomer services.
610	1	0	_aUnited States. _bDrug Enforcement Administration _xRules and practice.
650		0	_aOpioids _xOverdose _xPrevention _xGovernment policy _zUnited States.
650		0	_aDrug control _zUnited States.
650		0	_aOpioid abuse _zUnited States.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8